Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick-Pascal Strunz

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Zeitschrift Fur Rheumatologie|June 4, 2025
[Severe late-onset neutropenia after rituximab administration]Carla E Schütte, Christina Hillebrecht, Jens G Kuipers, et al.
Frontiers in Immunology|December 4, 2023
Case Report: Effectiveness of secukinumab in systemic sclerosis with early skin progress after autologous hematopoietic stem cell transplantation and end-stage kidney diseasePatrick-Pascal Strunz, Hannah Labinsky, Lea-Kristin Nagler, et al.
Frontiers in Immunology|July 17, 2020
Autologous Stem Cell Transplantation in Common Variable Immunodeficiency: A Case of Successful Treatment of Severe Refractory Autoimmune EncephalitisMatthias Froehlich, Eva C Schwaneck, Michael Gernert, et al.
JMIR Mhealth and Uhealth|May 29, 2026
Patient-Centered Lupus Erythematosus Mobile Apps: Systematic Search and Cross-Sectional Evaluation by Patients and PhysiciansTassilo Dege, Antonia Ullmann, Caroline Glatzel, et al.
Rheumatology International|October 25, 2021
Lymphocyte subsets in the peripheral blood are disturbed in systemic sclerosis patients and can be changed by immunosuppressive medicationMichael Gernert, Hans-Peter Tony, Eva Christina Schwaneck, et al.
RMD Open|January 24, 2023
Erdheim-Chester disease with Rosai-Dorfman-like lesions: treatment with methotrexate, anakinra and upadacitinibJan Portegys, Anke Heidemeier, Andreas Rosenwald, et al.
BMC Rheumatology|July 9, 2025
Comparison of T cell response to vaccination in rheumatic patients treated with Janus kinase inhibitors and TNF inhibitorsSebastian Hüper, Florian Eisele, Johannes Duell, et al.
Zeitschrift Fur Rheumatologie|December 1, 2025
[Survey on primary care for rheumatology patients in Lower Franconia and the contribution of digital health]Patrick-Pascal Strunz, Michael Gernert, Lea-Kristin Nagler, et al.
Arthritis Research & Therapy|December 11, 2024
Clonal T cell populations scarcely impair patients with rheumatic diseases: a prospective long-term follow up studyMichael Gernert, Tobias Müller, Lukas Schweiker, et al.
Frontiers in Immunology|December 6, 2021
High Prevalence of Genital Human Papillomavirus Infection in Patients With Primary ImmunodeficienciesMichael Gernert, Matthias Kiesel, Matthias Fröhlich, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Zeitschrift Fur Rheumatologie|June 4, 2025
[Severe late-onset neutropenia after rituximab administration]Carla E Schütte, Christina Hillebrecht, Jens G Kuipers, et al.
Frontiers in Immunology|December 4, 2023
Case Report: Effectiveness of secukinumab in systemic sclerosis with early skin progress after autologous hematopoietic stem cell transplantation and end-stage kidney diseasePatrick-Pascal Strunz, Hannah Labinsky, Lea-Kristin Nagler, et al.
Frontiers in Immunology|July 17, 2020
Autologous Stem Cell Transplantation in Common Variable Immunodeficiency: A Case of Successful Treatment of Severe Refractory Autoimmune EncephalitisMatthias Froehlich, Eva C Schwaneck, Michael Gernert, et al.
JMIR Mhealth and Uhealth|May 29, 2026
Patient-Centered Lupus Erythematosus Mobile Apps: Systematic Search and Cross-Sectional Evaluation by Patients and PhysiciansTassilo Dege, Antonia Ullmann, Caroline Glatzel, et al.
Rheumatology International|October 25, 2021
Lymphocyte subsets in the peripheral blood are disturbed in systemic sclerosis patients and can be changed by immunosuppressive medicationMichael Gernert, Hans-Peter Tony, Eva Christina Schwaneck, et al.
RMD Open|January 24, 2023
Erdheim-Chester disease with Rosai-Dorfman-like lesions: treatment with methotrexate, anakinra and upadacitinibJan Portegys, Anke Heidemeier, Andreas Rosenwald, et al.
BMC Rheumatology|July 9, 2025
Comparison of T cell response to vaccination in rheumatic patients treated with Janus kinase inhibitors and TNF inhibitorsSebastian Hüper, Florian Eisele, Johannes Duell, et al.
Zeitschrift Fur Rheumatologie|December 1, 2025
[Survey on primary care for rheumatology patients in Lower Franconia and the contribution of digital health]Patrick-Pascal Strunz, Michael Gernert, Lea-Kristin Nagler, et al.
Arthritis Research & Therapy|December 11, 2024
Clonal T cell populations scarcely impair patients with rheumatic diseases: a prospective long-term follow up studyMichael Gernert, Tobias Müller, Lukas Schweiker, et al.
Frontiers in Immunology|December 6, 2021
High Prevalence of Genital Human Papillomavirus Infection in Patients With Primary ImmunodeficienciesMichael Gernert, Matthias Kiesel, Matthias Fröhlich, et al.
Pageof 5